Intelence
NDC Package 53808-0787-1

11-digit billing NDC: 53808078701

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Intelence is ®Registered trademark of Tibotec Pharmaceuticals, in combination with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in antiretroviral treatment-experienced adult patients, who have evidence of viral replication and HIV-1 strains resistant to a non-nucleoside reverse transcriptase inhibitor (NNRTI) and other antiretroviral agents.This indication is based on Week 48 analyses from 2 randomized, double-blind, placebo-controlled trials of INTELENCE®. Marketed by State Of Florida Doh Central Pharmacy, this product is identified by NDC 53808-0787 and is authorized under FDA application NDA022187.

Identification & Billing

NDC Package Code
53808-0787-1
Package Description
30 TABLET in 1 BLISTER PACK
Product Code
11-Digit Billing Format
53808078701
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Intelence
Dosage Form
-
Usage Information
INTELENCE®Registered trademark of Tibotec Pharmaceuticals, in combination with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in antiretroviral treatment-experienced adult patients, who have evidence of viral replication and HIV-1 strains resistant to a non-nucleoside reverse transcriptase inhibitor (NNRTI) and other antiretroviral agents.This indication is based on Week 48 analyses from 2 randomized, double-blind, placebo-controlled trials of INTELENCE®. Both studies were conducted in clinically advanced, 3-class antiretroviral (NNRTI, N[t]RTI, PI) treatment-experienced adults.The following points should be considered when initiating therapy with INTELENCE®:Treatment history and, when available, resistance testing, should guide the use of INTELENCE®.The use of other active antiretroviral agents with INTELENCE® is associated with an increased likelihood of treatment response.In patients who have experienced virologic failure on an NNRTI-containing regimen, do not use INTELENCE® in combination with only N[t]RTIs [see Clinical Studies (14)].The risks and benefits of INTELENCE® have not been established in pediatric patients or in treatment-naïve adult patients.

Regulatory & Marketing

Labeler Name
State Of Florida Doh Central Pharmacy
FDA Application #
NDA022187
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
07-01-2009
Listing Expiration
12-31-2018
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 53808-0787-1 identifies a specific commercial package of 30 tablet in 1 blister pack of Intelence, labeled by State Of Florida Doh Central Pharmacy. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by State Of Florida Doh Central Pharmacy on July 01, 2009. The current certification is valid through December 31, 2018.

How is this State Of Florida Doh Central Pharmacy product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 53808078701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
53808-0787-1
11-Digit CMS (5-4-2)
53808-0787-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.